{"id":"CHEMBL1082354","canonicalSmiles":"O=C(Nc1ncc([N+](=O)[O-])s1)c1cccs1","inchiKey":"ZLOXYEZYWCTXHU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TENONITROZOLE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Atrican","Tenonitrozole"],"crossReferences":{"PubChem":["144205515","170466466","29216349","50085892"],"Wikipedia":["Tenonitrozole"],"drugbank":["DB13659"]},"childChemblIds":["CHEMBL1388738"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1090777","canonicalSmiles":"O=S(=O)(c1ccc2c(c1)OCCO2)N1CCN(S(=O)(=O)c2c(F)cccc2F)CC1","inchiKey":"SHWNKRPMUBFWKE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1090777","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["57646217","85267861","87225658","99431014"],"drugbank":["DB07692"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL109648","canonicalSmiles":"COc1ccccc1Oc1c(NS(=O)(=O)c2ccc(C)cn2)nc(-c2ccnc(-c3nn[nH]n3)c2)nc1OCCO","inchiKey":"LFWCJABOXHSRGC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CLAZOSENTAN","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Pivlaz"],"synonyms":["ACT-108475","AXV-034343","AXV-343434","Axv-034","Clazosentan","RO-61-1790","Ro 61-1790","VML-588"],"crossReferences":{"drugbank":["DB06677"]},"linkedTargets":{"rows":["ENSG00000151617"],"count":1},"linkedDiseases":{"rows":["EFO_0000713"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL1152","canonicalSmiles":"CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C","inchiKey":"LRJOMUJRLNCICJ-JZYPGELDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PREDNISOLONE ACETATE","yearOfFirstApproval":1955,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Econopred","Flo-pred","Meticortelone","Omnipred","Pred forte","Pred fte","Pred mild","Prednisolone acetate","Sterane","Ultracortenol"],"synonyms":["NSC-10966","Prednisolone 21-acetate","Prednisolone Acetate","Prednisolone acetate","Prednisoloni acetas"],"crossReferences":{"DailyMed":["prednisolone%20acetate"],"PubChem":["144204881","170464632","56422451","855649"],"drugbank":["DB15566"],"chEBI":["8380"]},"linkedTargets":{"rows":["ENSG00000113580"],"count":1},"linkedDiseases":{"rows":["HP_0007957","EFO_1000811","MONDO_0003005","EFO_1000997","EFO_1000879","MONDO_0017634","EFO_1000906","HP_0000559","EFO_1001157","EFO_0003770","EFO_1001888","EFO_0005773","HP_0001742","HP_0011868","HP_0004798","MP_0001845","EFO_1001231","EFO_0000678","MONDO_0002280","MONDO_0005301","MONDO_0005129","HP_0003419","EFO_0007141","EFO_0009552","EFO_0005752"],"count":25},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1955 and has 7 approved and 9 investigational indications."}
{"id":"CHEMBL1161221","canonicalSmiles":"O=P(O)(O)C(F)(F)c1ccc2ccc(C(F)(F)P(=O)(O)O)cc2c1","inchiKey":"VHKBLEYUHBIBNR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1161221","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03154"]},"childChemblIds":["CHEMBL119459"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1164608","canonicalSmiles":"O=C(NC(=O)c1c(F)cccc1F)Nc1ccc(Cl)c(Oc2ncc(C(F)(F)F)cc2Cl)c1","inchiKey":"YOWNVPAUWYHLQX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FLUAZURON","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Acatak pour-on","Fluazuron"],"crossReferences":{"PubChem":["144205899","225144272","29217963"],"drugbank":["DB15583"],"chEBI":["39374"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1197051","canonicalSmiles":"CC(COc1ccccc1)NC(C)C(O)c1ccc(O)cc1","inchiKey":"BMUKKTUHUDJSNZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ISOXSUPRINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Dilator","Isoxsuprine"],"crossReferences":{"Wikipedia":["Isoxsuprine"]},"childChemblIds":["CHEMBL559180"],"linkedTargets":{"rows":["ENSG00000169252","ENSG00000171873","ENSG00000170214","ENSG00000120907"],"count":4},"linkedDiseases":{"rows":["MONDO_0005301"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV and has 1 investigational indication."}
{"id":"CHEMBL1198","canonicalSmiles":"CCCCOc1ccc(OCCCN2CCOCC2)cc1","inchiKey":"DQKXQSGTHWVTAD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PRAMOXINE","yearOfFirstApproval":1976,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Pramocaine","Pramoxine"],"crossReferences":{"DailyMed":["pramoxine%20hydrochloride"],"PubChem":["11112434"],"Wikipedia":["Pramocaine"],"drugbank":["DB09345"],"chEBI":["8357"]},"childChemblIds":["CHEMBL1201171"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1976 and has 5 approved indications."}
{"id":"CHEMBL1200517","canonicalSmiles":"CN1C[C@H](C(=O)N[C@]2(C)O[C@@]3(O)[C@@H]4CCCN4C(=O)[C@H](Cc4ccccc4)N3C2=O)C[C@@H]2c3cccc4[nH]cc(c34)C[C@H]21.CS(=O)(=O)O","inchiKey":"ADYPXRFPBQGGAH-UMYZUSPBSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"DIHYDROERGOTAMINE MESYLATE","yearOfFirstApproval":1946,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1732","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["D.h.e. 45","Diergo","Dihydergot","Dihydroergotamine mesylate","Tonopan"],"synonyms":["DHE-45","Dihydroergotamine Methanesulfonate","Dihydroergotamine mesilate","Dihydroergotamine mesylate","Dihydroergotamine methanesulfonate","Migranal","NSC-759848"],"crossReferences":{"DailyMed":["dihydroergotamine%20mesylate"],"PubChem":["50106120"],"chEBI":["59756"]},"linkedTargets":{"rows":["ENSG00000179546"],"count":1},"linkedDiseases":{"rows":["MONDO_0005277"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1946 and is indicated for migraine disorder. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1200557","drugType":"Small molecule","blackBoxWarning":false,"name":"MANGANESE SULFATE","yearOfFirstApproval":1987,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Manganese sulfate"],"crossReferences":{"Wikipedia":["Manganese(II)_sulfate"],"chEBI":["86360"]},"childChemblIds":["CHEMBL2103742"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1987 and has 3 approved indications."}
{"id":"CHEMBL1200617","canonicalSmiles":"CCC(=O)[C@@]1(C)[C@H](C)C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@]4(C)[C@H]3[C@@H](O)C[C@@]21C","inchiKey":"QTTRZHGPGKRAFB-OOKHYKNYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RIMEXOLONE","yearOfFirstApproval":1994,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Vexol"],"synonyms":["ORG 6216","ORG-6216","Rimexolon","Rimexolone"],"crossReferences":{"PubChem":["56463550"],"Wikipedia":["Rimexolone"],"drugbank":["DB00896"]},"linkedTargets":{"rows":["ENSG00000113580"],"count":1},"linkedDiseases":{"rows":["EFO_1000906","EFO_0005752"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1994 and is indicated for eye inflammation and has 1 investigational indication."}
{"id":"CHEMBL1200772","canonicalSmiles":"CC(=O)CC(c1ccccc1)c1c([O-])c2ccccc2oc1=O.[K+]","inchiKey":"WSHYKIAQCMIPTB-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"WARFARIN POTASSIUM","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1464","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Athrombin-k"],"synonyms":["Potassium warfarin","Warfarin potassium","Warfarin-potassium"],"crossReferences":{"PubChem":["144205190","170464790"]},"linkedTargets":{"rows":["ENSG00000167397"],"count":1},"linkedDiseases":{"rows":["HP_0001907","EFO_0000275","EFO_0003907"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1982 and has 3 investigational indications."}
{"id":"CHEMBL1200972","canonicalSmiles":"CN(C)CCC(O)(c1ccccc1)c1ccccc1Cl.Cl","inchiKey":"XYGSFNHCFFAJPO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHLOPHEDIANOL HYDROCHLORIDE","yearOfFirstApproval":1982,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL1201313","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["BAYER-186","Chlophedianol hcl","Chlophedianol hydrochloride","Clofedanol hydrochloride","Coldrin","Pectolitan","SL 501","SL-501","Sk-74","Ulone"],"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1982."}
{"id":"CHEMBL1201567","drugType":"Protein","blackBoxWarning":false,"name":"FILGRASTIM","yearOfFirstApproval":1991,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Accofil","Neupogen","Neupogen 30","Neupogen 48","Nivestim","Zarzio"],"synonyms":["Filgrastim","Filgrastim for bioassay","Filgrastim-sndz","Granulocyte colony-stimulating factor filgrastim","KRN-8601","MBRI-9901","R-METHUG-CSF","TX-01","TX01","Tbo-filgrastim","XM-02","XM02"],"crossReferences":{"DailyMed":["filgrastim","filgrastim-aafi","filgrastim-sndz","tbo-filgrastim"],"DrugCentral":["4987"],"Wikipedia":["Filgrastim"]},"linkedTargets":{"rows":["ENSG00000119535"],"count":1},"linkedDiseases":{"rows":["EFO_0003811","EFO_0000637","EFO_0004708","EFO_0011061","EFO_0003859","MONDO_0003751","EFO_0000756","EFO_0000681","EFO_1000231","HP_0031217","EFO_1001345","EFO_0005952","Orphanet_85443","EFO_1000984","EFO_1001951","EFO_0006803","EFO_1001952","EFO_1000318","MONDO_0015760","EFO_0000339","EFO_0000096","EFO_0002690","MONDO_0002974","MONDO_0008903","EFO_1000632","EFO_0002918","EFO_0000514","MONDO_0004976","EFO_0004991","EFO_0000760","EFO_0000407","EFO_0000198","EFO_0002618","MONDO_0013730","EFO_0000221","MONDO_0019465","EFO_0001642","EFO_1001946","EFO_1001968","MONDO_0004986","EFO_0000384","MONDO_0008315","HP_0001399","MONDO_0002691","EFO_0001422","EFO_1001365","MONDO_0044889","EFO_0003032","MONDO_0018201","EFO_0000574","EFO_0004256","EFO_0001378","EFO_1000796","EFO_1000550","EFO_0001376","Orphanet_84","MONDO_0044903","Orphanet_303","EFO_0007416","EFO_0007498","EFO_1001465","MONDO_0007254","Orphanet_790","EFO_0004252","MONDO_0003541","MONDO_0020654","EFO_0002430","MONDO_0001056","MONDO_0002158","EFO_1001974","MONDO_0005180","EFO_0004289","EFO_1000630","EFO_0000196","EFO_0000183","EFO_0000616","EFO_0006859","EFO_1001779","MONDO_0019457","EFO_0001645","EFO_0000403","EFO_1001042","EFO_0000222","MONDO_0000870","MONDO_0007576","EFO_0003929","EFO_1001953","EFO_1000954","EFO_0000764","MONDO_0011962","EFO_0007359","EFO_0000702","EFO_1001947","MONDO_0002367","EFO_0006927","MONDO_0018906","MONDO_0024880","EFO_0004265","EFO_0003869","MONDO_0000873","Orphanet_183660","EFO_0004281","MONDO_0003783","MONDO_0000956","EFO_1000131","MONDO_0004222","EFO_0000565","EFO_0000309","EFO_0004251","Orphanet_178","EFO_0000544","HP_0001871","MONDO_0019088","EFO_0000389","EFO_0000182","EFO_0000330","HP_0008209","MONDO_0019460","EFO_0000094","EFO_1000749","Orphanet_654","EFO_0009441","EFO_0003802","EFO_0003893","EFO_0000466","EFO_0000220","EFO_0004145","MONDO_0008170","EFO_0000223","EFO_0002939","MONDO_0044881","EFO_0000224","EFO_0003025","EFO_0009708","EFO_0006926","MONDO_0001208","EFO_1000238","EFO_0005537","EFO_0002428","EFO_0000218","MONDO_0002334","EFO_0003922","MONDO_0009348","Orphanet_30391","MONDO_0019471","EFO_0003812","Orphanet_232","MONDO_0004192","MONDO_0044887","EFO_1001945","MONDO_0002041","HP_0001915","MONDO_0002087","EFO_1001469","EFO_0000209","EFO_1000357","MONDO_0001187","EFO_0007362","EFO_1000218","EFO_1000043","MONDO_0001475","EFO_0000712","MONDO_0001657","EFO_0004272","MONDO_0020743","EFO_0000717","EFO_1001963","EFO_0000239","EFO_1000158","EFO_0003928","HP_0002140","EFO_0000545","EFO_0003875","HP_0001945","EFO_0005529","EFO_0000556","EFO_0000313","EFO_0000621","EFO_0003060","EFO_0003029","EFO_0000311","EFO_0000211","MONDO_0005301","EFO_0000095","EFO_0000174","EFO_0006861","MONDO_0005147","EFO_0001421","EFO_0006475","EFO_0000191","EFO_0004142","EFO_0008583","EFO_0005235","EFO_0000612","MONDO_0004975","MONDO_0020077","EFO_0003833","EFO_0000691","MONDO_0004643","EFO_0000181","EFO_0003027","HP_0012410"],"count":202},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1991 and has 4 approved and 164 investigational indications."}
{"id":"CHEMBL1201644","drugType":"Protein","blackBoxWarning":false,"name":"INSULIN ZINC SUSP RECOMBINANT HUMAN","yearOfFirstApproval":1985,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Humulin l","Novolin l"],"synonyms":["Insulin zinc susp recombinant human"],"linkedTargets":{"rows":["ENSG00000171105"],"count":1},"linkedDiseases":{"rows":["EFO_0000400"],"count":1},"description":"Protein drug with a maximum clinical trial phase of IV that was first approved in 1985 and has 1 investigational indication."}
{"id":"CHEMBL1201754","canonicalSmiles":"NC(=O)c1cn(Cc2c(F)cccc2F)nn1","inchiKey":"POGQSBRIGCQNEG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RUFINAMIDE","yearOfFirstApproval":2008,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Banzel","Inovelon","Rufinamide"],"synonyms":["60231/4","CGP 33101","CGP-33101","E-2080","E2080","RUF 331","RUF-331","Rufinamide"],"crossReferences":{"DailyMed":["rufinamide"],"PubChem":["170465202","29217641","50111716","56320687","90341717"],"Wikipedia":["Rufinamide"],"drugbank":["DB06201"]},"linkedTargets":{"rows":["ENSG00000185313","ENSG00000196876","ENSG00000183873","ENSG00000136546","ENSG00000144285","ENSG00000169432","ENSG00000168356","ENSG00000136531","ENSG00000007314","ENSG00000153253"],"count":10},"linkedDiseases":{"rows":["EFO_0000474","HP_0001250","Orphanet_2382","EFO_0003843"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2008 and has 3 approved and 1 investigational indication."}
{"id":"CHEMBL1201798","canonicalSmiles":"C=CCN.ClCC1CO1","inchiKey":"ZNSIZMQNQCNRBW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SEVELAMER","yearOfFirstApproval":2007,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Renagel","Renvela"],"synonyms":["Sevelamer","Sevelamer anhydrous"],"crossReferences":{"DailyMed":["sevelamer%20carbonate"],"DrugCentral":["4324"],"drugbank":["DB00658"]},"childChemblIds":["CHEMBL1201799"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2007 and is indicated for chronic kidney disease and has 4 investigational indications."}
{"id":"CHEMBL1213604","canonicalSmiles":"CCCC1=N[C@H]2[C@H](O[C@H](CO)[C@@H](O)[C@@H]2O)S1","inchiKey":"QWOPEBCGKASVQP-QXOHVQIXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1213604","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08255"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1233881","canonicalSmiles":"COc1ccc(-c2nn(C3CCC3)c3ncnc(N)c23)cc1OC","inchiKey":"ITOYZJGFTNTKKR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1233881","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08053"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1234416","canonicalSmiles":"Cc1nc(N)nc2c1/C(=N/O)C[C@@H](c1ccc(F)cc1-c1cccnc1)C2","inchiKey":"KYIXUSLGFINPTC-WVFAEZDRSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1234416","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08197"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1234777","canonicalSmiles":"N=C(NO)NCC[C@H](N)C(=O)O","inchiKey":"KOBHCUDVWOTEKO-VKHMYHEASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL1234777","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02381"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1236642","canonicalSmiles":"CCCCCC/C=C\\CCCCCCCCCC(=O)O","inchiKey":"UWHZIFQPPBDJPM-FPLPWBNLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VACCENIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Vaccenic acid"],"crossReferences":{"drugbank":["DB04801"],"chEBI":["50464"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1236962","canonicalSmiles":"COc1ncc(-c2ccc3nccc(-c4ccnnc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F","inchiKey":"CGBJSGAELGCMKE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OMIPALISIB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GSK-2126458","GSK2126458","Gsk-2126458","Omipalisib"],"crossReferences":{"drugbank":["DB12703"]},"linkedTargets":{"rows":["ENSG00000145675","ENSG00000171608","ENSG00000105647","ENSG00000141506","ENSG00000051382","ENSG00000121879","ENSG00000105851","ENSG00000117461","ENSG00000198793"],"count":9},"linkedDiseases":{"rows":["EFO_0000616","EFO_0000768","EFO_0000311"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL1237174","canonicalSmiles":"NN","inchiKey":"OAKJQQAXSVQMHS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"HYDRAZINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Diamine","Diazane","Hydrazine"],"crossReferences":{"Wikipedia":["Hydrazine"],"chEBI":["15571"]},"childChemblIds":["CHEMBL542171","CHEMBL1981828"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1255943","canonicalSmiles":"Cl.N[C@@H](CCC(=O)O)C(=O)O","inchiKey":"RPAJSBKBKSSMLJ-DFWYDOINSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GLUTAMIC ACID HYDROCHLORIDE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Muripsin"],"synonyms":["Glutamic acid hcl","Glutamic acid hydrochloride","L-Glutamic Acid HCl","L-glutamic acid hydrochloride","NSC-9239"],"crossReferences":{"PubChem":["144212969","50106317","56463636"]},"description":"Small molecule drug with a maximum clinical trial phase of IV."}
{"id":"CHEMBL1334078","canonicalSmiles":"[Na+].[O-]Cl","inchiKey":"SUKJFIGYRHOWBL-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SODIUM HYPOCHLORITE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL1616046","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Actichlor","Chlorasol","Milton in emuls wax","Milton in liq paraf","Milton no.2"],"synonyms":["Antiformin, dental","Clorox","Dakin's solution","Dental antiformin","Household bleach","Hypochlorous acid, sodium salt","Natrum hypochlorosum","Sodium hypochlorite","Sodium hypochlorite [solution, diluted]"],"crossReferences":{"DrugCentral":["4790"],"PubChem":["17389733"],"chEBI":["32146"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL141247","canonicalSmiles":"O=C(Nc1ccccn1)Nc1cccc2c1[C@H]1CCCN1C2=O","inchiKey":"KLVYMYQTRZCMLE-CYBMUJFWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL141247","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04186"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1420","canonicalSmiles":"C[n+]1ccccc1C=NO","inchiKey":"JBKPUQTUERUYQE-UHFFFAOYSA-O","drugType":"Small molecule","blackBoxWarning":false,"name":"PRALIDOXIME","yearOfFirstApproval":1964,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Atnaa","Duodote","Pralidoxime","Pralidoxime cation","Pralidoxime ion"],"crossReferences":{"DailyMed":["pralidoxime%20chloride"],"PubChem":["11112108"],"Wikipedia":["Pralidoxime"],"drugbank":["DB00733"],"chEBI":["8354"]},"childChemblIds":["CHEMBL3335073","CHEMBL748","CHEMBL2104739","CHEMBL14577"],"linkedTargets":{"rows":["ENSG00000087085"],"count":1},"linkedDiseases":{"rows":["EFO_0010581","EFO_0008546","EFO_0004991"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1964 and is indicated for poisoning and myasthenia gravis and has 2 investigational indications."}
{"id":"CHEMBL14249","canonicalSmiles":"Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)OP(=O)(O)OP(=O)(O)O)[C@@H](O)[C@H]1O","inchiKey":"ZKHQWZAMYRWXGA-KQYNXXCUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ADENOSINE TRIPHOSPHATE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Adenosine 5'-triphosphoric acid","Adenosine triphosphate"],"crossReferences":{"PubChem":["144205597","26514303","26756664"],"Wikipedia":["Adenosine_triphosphate"],"drugbank":["DB00171"],"chEBI":["15422"]},"childChemblIds":["CHEMBL1447572","CHEMBL2364734","CHEMBL2364735","CHEMBL2106579"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL1448187","canonicalSmiles":"Cl.Cl.OCCN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1","inchiKey":"MBHNWCYEGXQEIT-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"FLUPHENAZINE HYDROCHLORIDE","yearOfFirstApproval":1959,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL726","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Fluphenazine hydrochloride","Moditen","Permitil","Prolixin"],"synonyms":["Fluphenazine dihydrochloride","Fluphenazine hydrochloride","NSC-179197","SQUIBB 4918"],"crossReferences":{"DailyMed":["fluphenazine%20hydrochloride"],"PubChem":["26747520","26747521","50106350"]},"linkedTargets":{"rows":["ENSG00000149295"],"count":1},"linkedDiseases":{"rows":["EFO_0001378"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 1959 and has 1 investigational indication. This drug has a black box warning from the FDA."}
{"id":"CHEMBL150","canonicalSmiles":"O=c1c(O)c(-c2ccc(O)cc2)oc2cc(O)cc(O)c12","inchiKey":"IYRMWMYZSQPJKC-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"KAEMPFEROL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Kaempferol","Kempferol","Pelargidenolon","Populnetin","Rhamnolutein","Rhamnolutin","Robigenin","Swartziol","Trifolitin"],"crossReferences":{"PubChem":["11112381","11112382","124882309","144208363","144213678","17389844","174007227","26757741","46501187","49674535","50105504"],"Wikipedia":["Kaempferol"],"drugbank":["DB01852"],"chEBI":["28499"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1512","canonicalSmiles":"CC1(C)O[C@@H]2C[C@H]3[C@@H]4C[C@H](F)C5=CC(=O)C=C[C@]5(C)[C@H]4[C@@H](O)C[C@]3(C)[C@]2(C(=O)CO)O1","inchiKey":"XSFJVAJPIHIPKU-XWCQMRHXSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FLUNISOLIDE","yearOfFirstApproval":1981,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Aerobid","Aerospan","Aerospan hfa","Flunisolide","Nasalide","Nasarel","Syntaris","Syntaris hayfever"],"synonyms":["Flunisolide","Flunisolide anhydrous","Flunisolide hemihydrate","NSC-757871","RS-3999"],"crossReferences":{"DailyMed":["flunisolide"],"PubChem":["144204276","170465331","56463079"],"Wikipedia":["Flunisolide"],"drugbank":["DB00180"],"chEBI":["5106"]},"linkedTargets":{"rows":["ENSG00000113580"],"count":1},"linkedDiseases":{"rows":["EFO_0008521","HP_0006536","MONDO_0004979","EFO_1001417","HP_0001742"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1981 and has 4 approved and 1 investigational indication."}
{"id":"CHEMBL1552157","canonicalSmiles":"CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C","inchiKey":"PRAKJMSDJKAYCZ-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SQUALANE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NSC-6851","Pripure 3759","Squalane"],"crossReferences":{"PubChem":["144205830","170465658","29217734"],"drugbank":["DB11420"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL15768","canonicalSmiles":"CC12CCC(CC1=O)C2(C)C","inchiKey":"DSSYKIVIOFKYAU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL15768","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144207435"],"Wikipedia":["Camphor"],"drugbank":["DB14156"],"chEBI":["36773"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL15913","canonicalSmiles":"Nc1cc[nH]c(=O)n1","inchiKey":"OPTASPLRGRRNAP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CYTOSINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cytosine","Lamivudine impurity c","Lamivudine impurity c rs","NSC-27787"],"crossReferences":{"PubChem":["144212456","56322619"],"Wikipedia":["Cytosine"],"chEBI":["16040"]},"childChemblIds":["CHEMBL2028229"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL159820","canonicalSmiles":"O=C(O)Cn1ccc(=O)n(Cc2nc3cc(Cl)ccc3s2)c1=O","inchiKey":"RQWICELTTDJODO-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL159820","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07093"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1651913","canonicalSmiles":"COc1cccc(C(=O)CCN[C@@H](C)[C@H](O)c2ccccc2)c1","inchiKey":"GDYUVHBMFVMBAF-LIRRHRJNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OXYFEDRINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(-)-oxyfedrine","Oxyfedrine","Oxyfedrine hydrochloride"],"crossReferences":{"drugbank":["DB13398"]},"childChemblIds":["CHEMBL2354521"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL1665","canonicalSmiles":"CCC[S+]([O-])c1ccc2[nH]c(NC(=O)OC)nc2c1","inchiKey":"VXTGHWHFYNYFFV-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ALBENDAZOLE OXIDE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Albendazole oxide","Albendazole sulfoxide","RS 8852","RS-8852","Ricobendazole","Rycoben","Rycobendazole"],"crossReferences":{"PubChem":["170466291","174006227"],"drugbank":["DB13871"],"chEBI":["16959"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL1694","canonicalSmiles":"CCOC(=O)[C@H](CCc1ccccc1)N[C@H]1CCc2ccccc2N(CC(=O)O)C1=O.Cl","inchiKey":"VPSRQEHTHIMDQM-FKLPMGAJSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"BENAZEPRIL HYDROCHLORIDE","yearOfFirstApproval":1991,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL838","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Benazepril hydrochloride","Cibacen","Lotensin"],"synonyms":["Benazepril hcl","Benazepril hydrochloride","CGS 14824A HCL","CGS-14824A","CGS-14824A HCL","NSC-758920"],"crossReferences":{"DailyMed":["benazepril%20hydrochloride"],"PubChem":["144204994","170465003","49648469"],"chEBI":["3012"]},"linkedTargets":{"rows":["ENSG00000159640"],"count":1},"linkedDiseases":{"rows":["EFO_0003086","Orphanet_79292","EFO_1000965","EFO_0000712","Orphanet_88917","EFO_0000400","EFO_1002048","EFO_0000537"],"count":8},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1991 and has 4 approved and 4 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL1743053","drugType":"Antibody","blackBoxWarning":false,"name":"OTELIXIZUMAB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CHAGLY CD3","CHAGLYCD-3","ChAglyCD","Chaglycd3","Otelixizumab","TRX-4","TRX4"],"linkedTargets":{"rows":["ENSG00000198851"],"count":1},"linkedDiseases":{"rows":["EFO_0000685","MONDO_0005147","EFO_1001466"],"count":3},"description":"Antibody drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL183","canonicalSmiles":"CCCn1c(=O)c2[nH]c(C3CCCC3)nc2n(CCC)c1=O","inchiKey":"FFBDFADSZUINTG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"1,3-DIPROPYL-8-CYCLOPENTYLXANTHINE [DPCPX]","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GNF-Pf-2224"],"crossReferences":{"PubChem":["11110874","11113351","50104134","56422903","85230944","855876","90341492"],"Wikipedia":["Dipropylcyclopentylxanthine"],"drugbank":["DB12946"],"chEBI":["73282"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL184048","canonicalSmiles":"N=C(N)c1ccc(CO)cc1","inchiKey":"WHMKAFNJMLEDSN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"4-Hydroxymethyl-Benzamidine","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["4-Hydroxymethyl-Benzamidine"],"crossReferences":{"drugbank":["DB02585"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL185595","canonicalSmiles":"O=C(O)CCCn1c2ccccc2c2ccccc21","inchiKey":"HQAKVYGASUTQHH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL185595","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03851"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL18591","canonicalSmiles":"O=C(O)C1=NCCC1","inchiKey":"RHTAIKJZSXNELN-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL18591","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02838"],"chEBI":["36761"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2016757","canonicalSmiles":"N#C[C@@]1(c2ccc3c(N)ncnn23)O[C@H](CO)[C@@H](O)[C@H]1O","inchiKey":"BRDWIEOJOWJCLU-LTGWCKQJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GS-441524","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Gs 441524","Gs-441524","Gs441524"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2103881","canonicalSmiles":"CN[C@@]1(C)[C@@H]2CC[C@@H](C2)C1(C)C","inchiKey":"IMYZQPCYWPFTAG-NGZCFLSTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEXMECAMYLAMINE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dexmecamylamine","NIH-11008","TC-5214","Tc-5214"],"crossReferences":{"drugbank":["DB11807"]},"childChemblIds":["CHEMBL2105753"],"linkedTargets":{"rows":["ENSG00000160716","ENSG00000101204"],"count":2},"linkedDiseases":{"rows":["EFO_0003086","EFO_0003890","MONDO_0002009","HP_0000975","EFO_1000781","EFO_0000537"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL2104859","canonicalSmiles":"Cc1ncc(COC(=O)CCC(=O)OCCN(C)C)c(CO)c1O","inchiKey":"KTOAWCPDBUCJED-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PIRISUDANOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Pirisudanol","Pyrisuccideanol"],"crossReferences":{"drugbank":["DB13412"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2105700","canonicalSmiles":"COc1nc2ccc(Br)cc2cc1[C@@H](c1ccccc1)[C@@](O)(CCN(C)C)c1cccc2ccccc12.O=C(O)/C=C/C(=O)O","inchiKey":"ZLVSPMRFRHMMOY-WWCCMVHESA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"BEDAQUILINE FUMARATE","yearOfFirstApproval":2012,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL376488","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Sirturo"],"synonyms":["Bedaquiline fumarate","R-403323","R403323"],"crossReferences":{"DailyMed":["bedaquiline%20fumarate"],"chEBI":["72295"]},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2012 and is indicated for tuberculosis. This drug has a black box warning from the FDA."}
{"id":"CHEMBL2105710","canonicalSmiles":"CCCCC[C@H](O)c1ccc(N2C(=O)CC[C@@H]2COCc2ccc(C(=O)OC(C)C)s2)cc1","inchiKey":"MSIIJNOQQWRTFC-GGAORHGYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SIMENEPAG ISOPROPYL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AGN-210669","Simenepag isopropyl"],"crossReferences":{"drugbank":["DB12977"]},"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL2105743","canonicalSmiles":"COc1ccc(CC(C)(C)NC[C@H](O)c2cc(O)cc3c2OCC(=O)N3)cc1.Cl","inchiKey":"KCEHVJZZIGJAAW-FERBBOLQSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OLODATEROL HYDROCHLORIDE","yearOfFirstApproval":2014,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL605846","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Striverdi respimat"],"synonyms":["BI 1744 CL","BI-1744 CL","BI-1744-CL","Olodaterol hydrochloride"],"crossReferences":{"DailyMed":["olodaterol%20hydrochloride"],"chEBI":["83309"]},"linkedTargets":{"rows":["ENSG00000169252"],"count":1},"linkedDiseases":{"rows":["EFO_0000464","EFO_0006505","EFO_0000341"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2014 and has 3 approved indications."}
{"id":"CHEMBL2105747","canonicalSmiles":"COc1ccc(N2CCOCC2)c2sc(NC(=O)N3CCC(C)(O)CC3)nc12","inchiKey":"XNBRWUQWSKXMPW-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TOZADENANT","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["A-2A (3)","A2A (3)","A2A-(3)","RO-4494351","RO-4494351-000","RO-4494351-002","RO-4494351000","RO4494351","RO4494351-000","RO4494351-002","SYN-115","SYN115","Tozadenant"],"crossReferences":{"drugbank":["DB12203"]},"linkedTargets":{"rows":["ENSG00000128271"],"count":1},"linkedDiseases":{"rows":["EFO_0002610","MONDO_0005180","EFO_0001421"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2107720","canonicalSmiles":"CC(=O)CCC1C(=O)N(c2ccccc2)N(c2ccccc2)C1=O","inchiKey":"LGYTZKPVOAIUKX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"KEBUZONE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cetophenylbutazone","Kebuzone","Ketophenylbutazone"],"crossReferences":{"drugbank":["DB08940"],"chEBI":["31749"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL2107787","canonicalSmiles":"CC(=O)O[C@@]12CO[C@@H]1CC[C@@]1(C)[C@@H]3O[C@H](CN(C)C)O[C@@H]3C3=C(C)[C@@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c4ncccc4F)C[C@@](O)([C@@H](OC(=O)c4ccccc4)[C@H]21)C3(C)C","inchiKey":"MODVSQKJJIBWPZ-VLLPJHQWSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TESETAXEL","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Tesetaxel"],"crossReferences":{"drugbank":["DB12019"]},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL2107875","drugType":"Small molecule","blackBoxWarning":false,"name":"PATIROMER","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Patiromer"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2108336","drugType":"Protein","blackBoxWarning":false,"name":"LIXISENATIDE","yearOfFirstApproval":2016,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Adlyxin","Lyxumia"],"synonyms":["AVE 010","AVE-0010","AVE-010","AVE0010","Lixisenatide","ZP 10","ZP-10"],"crossReferences":{"DailyMed":["lixisenatide"]},"linkedTargets":{"rows":["ENSG00000112164"],"count":1},"linkedDiseases":{"rows":["MONDO_0005180","MONDO_0005147","MONDO_0005148","EFO_0000400","EFO_0005672"],"count":5},"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2016 and is indicated for diabetes mellitus and type 2 diabetes mellitus and has 3 investigational indications."}
{"id":"CHEMBL2108388","drugType":"Unknown","blackBoxWarning":false,"name":"FERUCARBOTRAN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Ferucarbotran","ZK 132281"],"description":"Unknown drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL2108446","drugType":"Unknown","blackBoxWarning":false,"name":"GUAR GUM","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Glucotard","Guarina","Lejguar"],"synonyms":["Cyamopsis tetragonoloba","Cyamopsis tetragonolobus","E-412","FEMA NO. 2537","Guar flour","Guar gum","Guaran","Gum-cyamopsis","INS NO.412","INS-412"],"description":"Unknown drug with a maximum clinical trial phase of IV (across all indications) and is indicated for diabetes mellitus and has 1 investigational indication."}
{"id":"CHEMBL2108569","drugType":"Protein","blackBoxWarning":false,"name":"INSULIN PEGLISPRO","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Insulin peglispro","LY-2605541","LY2605541"],"linkedTargets":{"rows":["ENSG00000171105"],"count":1},"linkedDiseases":{"rows":["MONDO_0005147","MONDO_0005148"],"count":2},"description":"Protein drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2108721","drugType":"Protein","blackBoxWarning":false,"name":"CENDERITIDE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CD-NP","Cenderitide"],"description":"Protein drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL2109142","drugType":"Oligosaccharide","blackBoxWarning":false,"name":"MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUP A","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Meningococcal polysaccharide vaccine group a","Meningococcus a, purified polysaccharides antigen"],"description":"Oligosaccharide drug with a maximum clinical trial phase of III and has 1 investigational indication."}
{"id":"CHEMBL2109385","drugType":"Antibody","blackBoxWarning":false,"name":"ENOTICUMAB","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Enoticumab","REGN-421","REGN421"],"description":"Antibody drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL2146102","canonicalSmiles":"CN[C@@H](C)[C@H](O)c1ccccc1.Cl","inchiKey":"BALXUFOVQVENIU-GNAZCLTHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EPHEDRINE HYDROCHLORIDE","yearOfFirstApproval":2021,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL211456","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Amesec","Asmapax","Bronchipax","C.a.m.","Do-do","Ephed hcl","Ephed in nor saline","Expurhin","Franol","Haymine","Rezipres","Secron","Tabasan","Taumasthman","Tedral","Tedral sa"],"synonyms":["(-)-ephedrine hydrochloride","Ephedrine hcl","Ephedrine hydrochloride","Ephedrini hydrochloridum","L-ephedrine hydrochloride","NSC-759611"],"crossReferences":{"PubChem":["144204863","170465509"]},"linkedTargets":{"rows":["ENSG00000184160","ENSG00000274286","ENSG00000169252","ENSG00000171873","ENSG00000170214","ENSG00000120907","ENSG00000043591","ENSG00000188778","ENSG00000150594"],"count":9},"linkedDiseases":{"rows":["EFO_0005251"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2021 and is indicated for hypotension."}
{"id":"CHEMBL21485","canonicalSmiles":"OB(O)c1ccccc1","inchiKey":"HXITXNWTGFUOAU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHENYLBORONIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Phenylboronic Acid"],"crossReferences":{"Wikipedia":["Phenylboronic_acid"],"drugbank":["DB01795"],"chEBI":["44923"]},"childChemblIds":["CHEMBL2207070"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL217068","canonicalSmiles":"N=C(N)NC(=O)Cn1c(-c2ccccc2)ccc1-c1ccccc1","inchiKey":"WVLDNAVUCUAGDP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL217068","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB06930"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL225157","canonicalSmiles":"CCOC(=O)C1=CCCC[C@H]1S(=O)(=O)Nc1ccc(F)cc1Cl","inchiKey":"LEEIJTHMHDMWLJ-CQSZACIVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RESATORVID","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Cli-095","Resatorvid","TAK-242","Tak-242"],"crossReferences":{"drugbank":["DB05943"]},"childChemblIds":["CHEMBL3527013"],"linkedTargets":{"rows":["ENSG00000136869"],"count":1},"linkedDiseases":{"rows":["HP_0100806","EFO_0007949"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL2303613","canonicalSmiles":"CO/N=C(\\C(=O)N[C@@H]1C(=O)N2C(C(=O)O)=C(CSc3nc(C)c(CC(=O)O)s3)CS[C@H]12)c1csc(N)n1","inchiKey":"XDZKBRJLTGRPSS-BGZQYGJUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CEFODIZIME","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Timecef"],"synonyms":["Cefodizime","Cefodizime disodium","Cefodizime disodium salt","Cefodizime sodium","HR 221","HR 221 [AS SODIUM]","HR-221","S 77 1221 B","S 77 1221 B [AS SODIUM]","S 77-1221B","S-77-1221-B","S-77-1221B","THR 221","THR 221 [AS SODIUM]","THR-221"],"crossReferences":{"drugbank":["DB13470"],"chEBI":["63214"]},"childChemblIds":["CHEMBL3189077"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for bacterial disease."}
{"id":"CHEMBL239857","canonicalSmiles":"COc1cccc(-c2cccc(CC[C@]3(C)CC(=O)N(C)C(N)=N3)c2)c1","inchiKey":"VDFBMQAUECXNKR-OAQYLSRUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL239857","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07519"]},"childChemblIds":["CHEMBL2437435"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL262135","drugType":"Protein","blackBoxWarning":false,"name":"GALLIUM OXODOTREOTIDE","yearOfFirstApproval":2016,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":[],"crossReferences":{"DailyMed":["gallium%20dotatate%20ga-68"]},"childChemblIds":["CHEMBL4297340"],"description":"Protein drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2016 and has 4 investigational indications."}
{"id":"CHEMBL270515","canonicalSmiles":"CC(C)C[C@H](NC(=O)[C@@H](NC(=O)c1cccc(-c2ccccc2)n1)[C@@H](C)O)B(O)O","inchiKey":"SJFBTAPEPRWNKH-CCKFTAQKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DELANZOMIB","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CEP 18770","CEP-18770","CIP 18770","CIP-18770","CT 47098","CT-47098","Delanzomib","NPH 007098","NPH-007098","NPH007098"],"crossReferences":{"drugbank":["DB11956"]},"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL278819","canonicalSmiles":"Cc1cc(-c2ccccc2)nnc1NCCN1CCOCC1","inchiKey":"LDMWSLGGVTVJPG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MINAPRINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":true,"isApproved":true,"withdrawnNotice":{"countries":["France"],"classes":["Neurotoxicity"],"year":1996},"tradeNames":["Cantor"],"synonyms":["AGR-1240","Brantur","CB-30038","Cantor","Minaprine"],"crossReferences":{"PubChem":["11112706"],"Wikipedia":["Minaprine"],"drugbank":["DB00805"],"chEBI":["51038"]},"childChemblIds":["CHEMBL536932","CHEMBL1364551"],"linkedTargets":{"rows":["ENSG00000135914","ENSG00000184845","ENSG00000149295","ENSG00000189221","ENSG00000102468","ENSG00000087085","ENSG00000168539","ENSG00000147246"],"count":8},"linkedDiseases":{"rows":["EFO_0003761"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for unipolar depression. It was withdrawn in France  in 1996 due to Neurotoxicity."}
{"id":"CHEMBL281786","canonicalSmiles":"CO[C@]12CC[C@@]3(C[C@@H]1C(C)(C)O)[C@H]1Cc4ccc(O)c5c4[C@@]3(CCN1CC1CC1)[C@H]2O5","inchiKey":"OIJXLIIMXHRJJH-KNLIIKEYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIPRENORPHINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["M50-50 injection"],"synonyms":["Diprenorfin","Diprenorphine","M-5050","M. 5050","M5050","Revivon"],"crossReferences":{"Wikipedia":["Diprenorphine"],"drugbank":["DB01548"],"chEBI":["4650"]},"childChemblIds":["CHEMBL2311186"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3039516","canonicalSmiles":"CCCCCCCC/C=C/CCCCCCCC(=O)OC[C@H]1O[C@@H](n2ccc(N)nc2=O)C(F)(F)[C@@H]1O","inchiKey":"HESSNRGIEVBPRB-QDDPNBLJSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GEMCITABINE ELAIDATE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CO-1.01","CO-101","CP-4126","Gemcitabine elaidate"],"crossReferences":{"drugbank":["DB12564"]},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL305686","canonicalSmiles":"Nc1ncnc2c1ncn2[C@@H]1O[C@H](CO)C[C@H]1O","inchiKey":"OFEZSBMBBKLLBJ-BAJZRUMYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CORDYCEPIN","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["3'-Deoxyadenosine","9-cordyceposidoadenine","Cordycepin","Cordycepine","NSC-401022","NSC-63984"],"crossReferences":{"PubChem":["47193882"],"Wikipedia":["Cordycepin"],"drugbank":["DB12156"],"chEBI":["29014"]},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3137691","canonicalSmiles":"CCN(CC)CCS(=O)(=O)[C@@H]1CCN2C(=O)c3coc(n3)CC(=O)C[C@H](O)/C=C(C)/C=C/CNC(=O)/C=C/[C@@H](C)[C@@H](C(C)C)OC(=O)[C@@H]12.CC[C@H]1NC(=O)[C@@H](NC(=O)c2ncccc2O)[C@@H](C)OC(=O)[C@H](c2ccccc2)NC(=O)[C@@H]2CC(=O)[C@H](CS[C@@H]3CN4CCC3CC4)CN2C(=O)[C@H](Cc2ccc(N(C)C)cc2)N(C)C(=O)[C@@H]2CCCN2C1=O","inchiKey":"PPKJUHVNTMYXOD-PZGPJMECSA-N","drugType":"Unknown","blackBoxWarning":false,"name":"QUINUPRISTIN/DALFOPRISTIN","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Synercid"],"synonyms":["Quinupristin/Dalfopristin","Quinupristin/dalfopristin","Synercid"],"description":"Unknown drug with a maximum clinical trial phase of IV (across all indications) and is indicated for bacterial disease and has 2 investigational indications."}
{"id":"CHEMBL3183184","canonicalSmiles":"CCCCC(CC)COC(=O)C=Cc1ccc(OC)cc1","inchiKey":"YBGZDTIWKVFICR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"OCTINOXATE","yearOfFirstApproval":1992,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Parsol"],"synonyms":["2-ethylhexyl p-methoxycinnamate","2-ethylhexyl-p-methoxycinnamate","Escalol 557","Escalol 557nb","Escalol 557t","Ethylhexyl methoxycinnamate","Ethylhexyl p-methoxycinnamate","Eusolex 2292","Eusolex uv-pearls omc","Jeescreen omc","NSC-26466","Neo heliopan av","Ocinoxate","Octinoxate","Octyl methoxycinnamate","Octyl p-methoxycinnamate","Parsol mcx","Parsol mcx-sa","Parsol mox","Solarom omc","Sun caps 664","Sunscreen av","Tinosorb omc","Uvinul 3088","Uvinul mc 80","Uvinul mc 80n","Uvinul mc 90","Uvinul mc80"],"crossReferences":{"PubChem":["144205495","144208525","170464894"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1992 and has 3 approved indications."}
{"id":"CHEMBL3184657","canonicalSmiles":"CC1(C)[C@H](C=C(Cl)Cl)[C@H]1C(=O)OCc1c(F)c(F)cc(F)c1F","inchiKey":"DDVNRFNDOPPVQJ-HQJQHLMTSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL3184657","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144206228"],"drugbank":["DB15117"],"chEBI":["32253"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL319118","canonicalSmiles":"COc1ccc(OC(F)(F)F)cc1CN[C@H]1CCCN[C@H]1c1ccccc1","inchiKey":"ZIWFCOIGUNPHPM-HKUYNNGSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CP-122721","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CP-122721"],"crossReferences":{"PubChem":["144210525"],"drugbank":["DB05421"]},"childChemblIds":["CHEMBL3215877"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL32573","canonicalSmiles":"c1cc2c(c(NC3=NCCN3)c1)CCCC2","inchiKey":"QQJLHRRUATVHED-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRAMAZOLINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Muconasal","Tramazoline"],"crossReferences":{"Wikipedia":["Tramazoline"],"drugbank":["DB13064"]},"childChemblIds":["CHEMBL2107640","CHEMBL1601957"],"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL338604","canonicalSmiles":"CCN(CC)CCNc1ccc2ncn3c4ccc(O)cc4c(=O)c1c23","inchiKey":"CUNDRHORZHFPLY-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"C-1311","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NSC-645809"],"childChemblIds":["CHEMBL3545337","CHEMBL2002951"],"description":"Small molecule drug with a maximum clinical trial phase of II."}
{"id":"CHEMBL341922","canonicalSmiles":"CC(C(=O)[O-])c1cccc(C(=O)c2ccccc2)c1.[Na+]","inchiKey":"OAPDLBHLMVYMCW-UHFFFAOYSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"KETOPROFEN SODIUM","maximumClinicalTrialPhase":2,"parentId":"CHEMBL571","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Diractin","Ketoprofen sodium","Sodium ketoprofen"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL354349","canonicalSmiles":"C[n+]1c2cc(N)ccc2cc2ccc(N)cc21.[Cl-]","inchiKey":"KKAJSJJFBSOMGS-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"EUFLAVINE","maximumClinicalTrialPhase":0,"parentId":"CHEMBL1184529","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Acriflavinium Chloride","Euflavine"],"crossReferences":{"PubChem":["26748314","93576781"],"Wikipedia":["Acriflavinium_chloride"],"drugbank":["DB13326"],"chEBI":["383703"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3545326","drugType":"Small molecule","blackBoxWarning":false,"name":"TAS-119","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Tas-119"],"linkedTargets":{"rows":["ENSG00000087586"],"count":1},"linkedDiseases":{"rows":["EFO_0000616"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3545401","drugType":"Small molecule","blackBoxWarning":false,"name":"X-82","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["X-82"],"linkedTargets":{"rows":["ENSG00000134853","ENSG00000128052","ENSG00000102755","ENSG00000037280","ENSG00000113721"],"count":5},"linkedDiseases":{"rows":["EFO_0000616","EFO_0003860","EFO_0001365","EFO_0000228"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL3580737","canonicalSmiles":"CCS(=O)(=O)c1ccc(Oc2cc(O[C@@H](C)CO)cc(C(=O)Nc3ccn(C)n3)c2)cn1","inchiKey":"KJSGTWFWVTYPFZ-AWEZNQCLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"MK-0941","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"childChemblIds":["CHEMBL4297302"],"linkedTargets":{"rows":["ENSG00000106633"],"count":1},"linkedDiseases":{"rows":["MONDO_0005148"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL360216","canonicalSmiles":"O=C1NCC(=O)N2CCC[C@@H]12","inchiKey":"OWOHLURDBZHNGG-YFKPBYRVSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL360216","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB04541"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL365468","canonicalSmiles":"O=C(O)[C@]1(O)C=C(F)[C@@H](O)[C@H](O)C1","inchiKey":"DGZQZSSRYAJDAX-XAHCXIQSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL365468","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02786"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL367588","canonicalSmiles":"Oc1ccc(-c2cc3cc(O)ccc3o2)cc1","inchiKey":"SNNNDCMXZYWCCI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL367588","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07032"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL3707283","canonicalSmiles":"CCOC(=O)[C@H]1O[C@H](O[C@H]2[C@@H](C(=O)OCO)O[C@H](O[C@H]3[C@@H](C(=O)OCO)O[C@H](O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@H]1O[C@H]1O[C@H](C(=O)OCO)[C@H](O)[C@H](O)[C@H]1O","inchiKey":"MTIIUKRETHUFRF-KLJDHDAFSA-N","drugType":"Oligosaccharide","blackBoxWarning":false,"name":"TETRAGALACTURONIC ACID HYDROXYMETHYLESTER","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Tetragalacturonic acid hydroxymethylester"],"description":"Oligosaccharide drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL3707340","canonicalSmiles":"Cc1c(Br)cc(Br)c(O)c1Br","inchiKey":"QKHROXOPRBWBDD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TRIBROMOMETACRESOL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Tribromometacresol"],"crossReferences":{"drugbank":["DB13513"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL37932","canonicalSmiles":"CCOC(=O)C(C)Oc1ccc(Oc2nc3ccc(Cl)cc3o2)cc1","inchiKey":"PQKBPHSEKWERTG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FENOXAPROP-ETHYL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"PubChem":["144211483","50113105"],"drugbank":["DB05252"],"chEBI":["5008"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL38","canonicalSmiles":"CC1=C(/C=C/C(C)=C/C=C/C(C)=C/C(=O)O)C(C)(C)CCC1","inchiKey":"SHGAZHPCJJPHSC-YCNIQYBTSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"TRETINOIN","yearOfFirstApproval":1971,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Acticin","Altreno","Atralin","Avita","Renova","Retin-a","Retin-a micro","Retin-a-micro","Tretin-X","Tretinoin","Vesanoid"],"synonyms":["Aberel","All-trans retinoic acid","All-trans-retinoic acid","Eudyna","Kerlocal","NSC-122758","Oristar rna","Retin a","Retinoic acid","Tretinoin"],"crossReferences":{"DailyMed":["tretinoin"],"PubChem":["104171346","124882949","124882951","124882956","124882957","144204363","144209528","144210625","170465045","26746936","29214999","416403","50103969","50103970","50126361","50126362","56422209","85231340","855632","90341365"],"Wikipedia":["Retinoic_acid","Tretinoin"],"drugbank":["DB00755"],"chEBI":["15367"]},"childChemblIds":["CHEMBL2051965"],"linkedTargets":{"rows":["ENSG00000131759","ENSG00000077092","ENSG00000172819"],"count":3},"linkedDiseases":{"rows":["EFO_0003869","EFO_0000756","EFO_0000464","MONDO_0007254","EFO_0000231","EFO_0000565","EFO_0004251","EFO_0007160","EFO_1000044","MONDO_0019098","MONDO_0002280","EFO_0000389","MONDO_0008903","EFO_0000330","EFO_0000673","EFO_0004826","EFO_0004193","MONDO_0004976","EFO_0000707","EFO_0000198","EFO_0000616","EFO_0002618","HP_0003124","EFO_0003963","MONDO_0022113","HP_0001065","MONDO_0021582","EFO_0003758","EFO_0000222","Orphanet_3389","EFO_0003894","EFO_0000224","EFO_0000621","EFO_0003060","EFO_0002496","MONDO_0044881","EFO_1000760","EFO_0004268","MONDO_0100096","EFO_0000702","EFO_0000574","MONDO_0002367","EFO_0001378","MONDO_0020077"],"count":44},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1971 and has 4 approved and 33 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL3833329","drugType":"Antibody","blackBoxWarning":false,"name":"ERENUMAB","yearOfFirstApproval":2018,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Aimovig"],"synonyms":["AMG 334","AMG-334","Erenumab","Erenumab-aooe"],"crossReferences":{"DailyMed":["erenumab-aooe"]},"linkedTargets":{"rows":["ENSG00000064989"],"count":1},"linkedDiseases":{"rows":["MONDO_0005277","EFO_1001219","EFO_0005279","EFO_0004149","EFO_0003913"],"count":5},"description":"Antibody drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2018 and is indicated for migraine disorder and has 3 investigational indications."}
{"id":"CHEMBL3916717","canonicalSmiles":"Cc1cc(F)c(C(=O)Nc2cccc(-c3nncn3C(C)C)n2)cc1-n1cnc(C2CC2)c1","inchiKey":"YIDDLAAKOYYGJG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"SELONSERTIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GS-4997","Gs-4997","Selonsertib"],"crossReferences":{"drugbank":["DB14916"]},"linkedTargets":{"rows":["ENSG00000197442"],"count":1},"linkedDiseases":{"rows":["EFO_0001361","EFO_0000401","EFO_1001249","EFO_1001345"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL3989690","canonicalSmiles":"CCOC[C@@H]1[C@@H](c2ccc(Cl)c(Cl)c2)C[C@@H]2CC[C@H]1N2C","inchiKey":"VCVWXKKWDOJNIT-ZOMKSWQUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"TESOFENSINE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NS 2330","NS-2330","Tesofensine"],"crossReferences":{"drugbank":["DB06156"]},"linkedTargets":{"rows":["ENSG00000108576","ENSG00000103546","ENSG00000142319"],"count":3},"linkedDiseases":{"rows":["Orphanet_739","MONDO_0005180","MONDO_0004975","EFO_0001073","MONDO_0005148"],"count":5},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 5 investigational indications."}
{"id":"CHEMBL3989914","canonicalSmiles":"COCCNCc1ccc(-c2cc3nccc(Oc4ccc(NC(=S)NC(=O)Cc5ccc(F)cc5)cc4F)c3s2)nc1","inchiKey":"YRCHYHRCBXNYNU-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"GLESATINIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Glesatinib","MG-90265","MG-90265X","MG90265","MG90265H9","MG90265X","MG90265gly","MGCD-265","MGCD265","Mgcd-265"],"crossReferences":{"drugbank":["DB06302"]},"linkedTargets":{"rows":["ENSG00000128052","ENSG00000102755","ENSG00000164078","ENSG00000037280","ENSG00000120156","ENSG00000105976"],"count":6},"linkedDiseases":{"rows":["EFO_0003060","EFO_0000311"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL399583","canonicalSmiles":"CCNC(=O)c1noc(-c2cc(C(C)(C)C)c(O)cc2O)c1-c1ccc(CN2CCOCC2)cc1","inchiKey":"WLYWTGDTMWWNNG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL399583","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB11881"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL40","canonicalSmiles":"CCC1(c2ccccc2)C(=O)NC(=O)NC1=O","inchiKey":"DDBREPKUVSBGFI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHENOBARBITAL","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Eskabarb","Luminal","Noptil","Phenobarbitone","Solfoton","Talpheno"],"synonyms":["NSC-128143","NSC-128143-","NSC-9848","Phenemal","Phenobarbital","Phenobarbital civ","Phenylethylmalonylurea"],"crossReferences":{"PubChem":["144207708","29215458","51087546"],"TG-GATEs":["4"],"Wikipedia":["Phenobarbital"],"drugbank":["DB01174"],"chEBI":["8069"]},"childChemblIds":["CHEMBL545356","CHEMBL149972"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and is indicated for epilepsy and has 9 investigational indications."}
{"id":"CHEMBL402744","canonicalSmiles":"O=C1C[C@@H](c2ccccc2)Oc2cc(O)ccc21","inchiKey":"SWAJPHCXKPCPQZ-AWEZNQCLSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"(2S)-7-Hydroxyflavanone","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(2S)-7-Hydroxyflavanone"],"crossReferences":{"drugbank":["DB04274"],"chEBI":["41888"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL409536","canonicalSmiles":"O=C(OCc1ccccc1)c1cn2c(=O)n(Cc3ccccc3)c(=O)cc2s1","inchiKey":"PLBINCOCFGQAJM-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL409536","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08561"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4130229","canonicalSmiles":"Cc1ccc(C(=O)NNC(=O)c2c(C)cccc2Cl)cc1C#Cc1cnc2ccccc2c1","inchiKey":"ZQOBVMHBVWNVBG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"VODOBATINIB","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["K-0706","K0706","Sco-088","Vodobatinib"],"linkedTargets":{"rows":["ENSG00000097007","ENSG00000186716"],"count":2},"linkedDiseases":{"rows":["EFO_0000339","MONDO_0005180","HP_0000726"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4204703","canonicalSmiles":"O[C@H]1CC[C@H](Nc2nc(-c3ccccc3)nc3[nH]ccc23)CC1","inchiKey":"RBZNJGHIKXAKQE-HDJSIYSDSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL4204703","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB12446"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL421584","canonicalSmiles":"O=[P@]1(N(CCCl)CCCl)N[C@H](OO)CCO1","inchiKey":"VPAWVRUHMJVRHU-VGDKGRGNSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL421584","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB12727"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4297066","canonicalSmiles":"CCCCCCCC(=O)N[C@H](CN1CCCC1)[C@H](O)c1ccc2c(c1)OCCO2.CCCCCCCC(=O)N[C@H](CN1CCCC1)[C@H](O)c1ccc2c(c1)OCCO2.O=C(O)C(O)C(O)C(=O)O","inchiKey":"KUBARPMUNHKBIQ-ZBPSDVLKSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ELIGLUSTAT TARTRATE","yearOfFirstApproval":2014,"maximumClinicalTrialPhase":4,"parentId":"CHEMBL2110588","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Cerdelga"],"synonyms":["Eliglustat hemitartrate","Eliglustat tartrate","GENZ 112638","GENZ-112638"],"crossReferences":{"DailyMed":["eliglustat%20tartrate"]},"linkedTargets":{"rows":["ENSG00000148154"],"count":1},"linkedDiseases":{"rows":["Orphanet_355"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of IV that was first approved in 2014 and is indicated for gaucher disease."}
{"id":"CHEMBL4297109","canonicalSmiles":"CC[N+]1(C)[C@H]2CC(OC(=O)[C@H](CO)c3ccccc3)C[C@@H]1[C@H]1O[C@@H]21.[Br-]","inchiKey":"LCELQERNWLBPSY-YAYGZGPXSA-M","drugType":"Small molecule","blackBoxWarning":false,"name":"OXITROPIUM BROMIDE","maximumClinicalTrialPhase":4,"parentId":"CHEMBL4297364","hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Oxivent"],"synonyms":["BA-253","BA253","Oxitropium bromide","Tersigan"],"description":"Small molecule drug with a maximum clinical trial phase of IV and is indicated for airway obstruction."}
{"id":"CHEMBL4297252","canonicalSmiles":"C[C@@H]1O[C@@H](O[C@H]2[C@H](O[C@H]([C@H](O)CO)[C@H](O)[C@@H](O)C=O)O[C@H](CO)[C@H](O)[C@@H]2O)[C@@H](O)[C@H](O)[C@@H]1O","inchiKey":"HWHQUWQCBPAQQH-BWRPKUOHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"2'-FUCOSYLLACTOSE","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2'-fucosyllactose","2'-o-fucosyllactose","2'-o-l-fucosyl-d-lactose","Lactose, 2'-o-fucosyl-"],"description":"Small molecule drug with a maximum clinical trial phase of I (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4297385","canonicalSmiles":"COC[C@@H]1[C@@H](c2ccc(Cl)c(Cl)c2)C[C@@H]2CC[C@H]1N2C","inchiKey":"PGYDXVBZYKQYCS-VPWBDBDCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"NS-2359","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["GSK-372,475","GSK-372475","GSK372475","Gsk372475","NS2359","Ns-2359","Ns2359"],"crossReferences":{"drugbank":["DB05805"]},"linkedTargets":{"rows":["ENSG00000108576","ENSG00000103546","ENSG00000142319"],"count":3},"linkedDiseases":{"rows":["EFO_0003888","EFO_0002610","MONDO_0002050","EFO_0010445"],"count":4},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4297441","canonicalSmiles":"CC/C=C\\C/C=C\\C/C=C\\C/C=C\\C/C=C\\C/C=C\\CCC(=O)O[C@@H](C(=O)O[C@H]1C[C@@]2(O)[C@@H](OC(=O)c3ccccc3)[C@H]3[C@](C)(C(=O)[C@H](OC(C)=O)C(=C1C)C2(C)C)[C@@H](O)C[C@H]1OC[C@]13OC(C)=O)[C@@H](NC(=O)c1ccccc1)c1ccccc1","inchiKey":"LRCZQSDQZJBHAF-PUBGEWHCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PACLITAXEL DOCOSAHEXAENOIC ACID","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Dha paclitaxel","Dha-paclitaxel","Paclitaxel docosahexaenoic acid","Paclitaxel-dha","Taxoprexin"],"crossReferences":{"drugbank":["DB05297"]},"linkedTargets":{"rows":["ENSG00000261456","ENSG00000188229","ENSG00000104833","ENSG00000137267","ENSG00000258947","ENSG00000101162","ENSG00000196230","ENSG00000137285","ENSG00000176014"],"count":9},"linkedDiseases":{"rows":["EFO_0000182","EFO_0003060","EFO_0002617"],"count":3},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4297593","canonicalSmiles":"CONC(=N)c1ccc(CNC(=O)[C@@H]2CCN2C(=O)[C@H](O)c2cc(Cl)cc(OC(F)F)c2)cc1","inchiKey":"XSNMGLZVFNDDPW-ZWKOTPCHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ATECEGATRAN METOXIL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["AZD-0837","AZD0837","Atecegatran fexenetil","Atecegatran metoxil","Azd 0837","Azd0837"],"crossReferences":{"drugbank":["DB12507"]},"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL4297786","drugType":"Unknown","blackBoxWarning":false,"name":"MK-8325","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Mk-8325"],"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4297887","drugType":"Unknown","blackBoxWarning":false,"name":"GSK-2586881","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["APN-01","APN01","Alunacedase alfa","Apn01","GSK-2586881","Gsk-2586881","Gsk2586881"],"linkedTargets":{"rows":["ENSG00000135744"],"count":1},"linkedDiseases":{"rows":["EFO_0004610","EFO_0001361","MONDO_0100096"],"count":3},"description":"Unknown drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4297923","drugType":"Protein","blackBoxWarning":false,"name":"RASDEGAFUSP ALFA","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CDX-1401","Cdx-1401","Rasdegafusp alfa"],"description":"Protein drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL44803","canonicalSmiles":"Nc1nc(O)c2nn(-c3cccc(C(=O)NCc4cc(Cl)cc(Cl)c4)c3)nc2n1","inchiKey":"JMQTXEWNXSPEKX-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL44803","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB03571"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL451635","canonicalSmiles":"O/N=C/c1cc[n+](COC[n+]2ccc(/C=N/O)cc2)cc1","inchiKey":"HIGRLDNHDGYWQJ-UHFFFAOYSA-P","drugType":"Small molecule","blackBoxWarning":false,"name":"OBIDOXIME","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Obidoxime"],"crossReferences":{"drugbank":["DB13750"]},"childChemblIds":["CHEMBL590824","CHEMBL291233"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL458966","canonicalSmiles":"N#Cc1ccc(COc2ccc3cc(S(=O)(=O)N[C@H](CCC(=O)O)C(=O)O)ccc3c2)cc1","inchiKey":"PUHRQSFXADUGJW-OAQYLSRUSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL458966","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB08108"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4594365","drugType":"Unknown","blackBoxWarning":false,"name":"REN-001","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["HPP-593","HPP593","Hpp593","REN-001","Ren-001"],"description":"Unknown drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL4594618","drugType":"Gene","blackBoxWarning":false,"name":"BREXUCABTAGENE AUTOLEUCEL","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Brexucabtagene autoleucel","KTE-X19"],"linkedTargets":{"rows":["ENSG00000177455"],"count":1},"linkedDiseases":{"rows":["EFO_0000220","EFO_0001642","EFO_0000095","EFO_1001469"],"count":4},"description":"Gene drug with a maximum clinical trial phase of II (across all indications) and has 3 investigational indications."}
{"id":"CHEMBL4594730","drugType":"Small molecule","blackBoxWarning":false,"name":"VIPIVOTIDE TETRAXETAN LUTETIUM","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"childChemblIds":["CHEMBL4594406"],"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL4650214","canonicalSmiles":"CN1CCC(c2ccccc2CC(C)(C)Nc2nc(N3CCOCC3)nc(-n3c(C(F)F)nc4ccccc43)n2)CC1","inchiKey":"WPFUFWIHMYZXSF-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ZANDELISIB","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["ACC-524","ME-401","Me-401","PW-143","PWT-143","PWT143","Pwt-143","Zandelisib"],"linkedTargets":{"rows":["ENSG00000171608"],"count":1},"linkedDiseases":{"rows":["EFO_0000096","EFO_0000095","EFO_0000403","MONDO_0018906","EFO_1001469","EFO_0000311"],"count":6},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL465183","canonicalSmiles":"CCCCC/C=C\\C/C=C\\C/C=C\\CCCCCCC(=O)O","inchiKey":"HOBAELRKJCKHQD-QNEBEIHSSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DIHOMO-GAMMA-LINOLENIC ACID","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[".gamma.-homolinolenic acid","20:3 (.omega.-6) fatty acid","20:3(N-6)","8z,11z,14z-eicosatrienoic acid","Bishomo-.gamma.-linolenic acid","Cis-8,11,14-Eicosatrienoicacid","DS-107G","DS107G","Daleuton","Dihomo-.gamma.-linolenic acid","Dihomo-gamma-linolenic acid","Diroleuton","Ds-107","Ds107","RO 12-1989"],"crossReferences":{"PubChem":["26754937","26754938"],"drugbank":["DB00154"],"chEBI":["53486"]},"childChemblIds":["CHEMBL3274189"],"description":"Small molecule drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL474857","canonicalSmiles":"O=C(N/N=C/c1cc(Br)c(O)c(Br)c1O)c1ccc(Br)cc1","inchiKey":"HKNUDJDAVYPTGD-NGYBGAFCSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL474857","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07098"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL477874","canonicalSmiles":"FC(F)(F)COCC(F)(F)F","inchiKey":"KGPPDNUWZNWPSI-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"FLUROTHYL","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":["Indoklon"],"synonyms":["Flurothyl","Flurotyl","Hexafluorodiethyl ether","NSC-760127","SK&F 6539"],"crossReferences":{"drugbank":["DB08969"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL4802199","drugType":"Unknown","blackBoxWarning":false,"name":"BBV-152 ANTIGEN ADJUVATED WITH ALGEL-IMDG","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Bbv-152 antigen adjuvated with algel-imdg","Covaxin"],"description":"Unknown drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL51969","canonicalSmiles":"COC(=O)[C@@H](N)Cc1ccccc1","inchiKey":"VSDUZFOSJDMAFZ-VIFPVBQESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PHENYLALANINE METHYL ESTER","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["(S)-Phenylalanine Methylester","L-Phenylalanine Methyl Ester"],"crossReferences":{"drugbank":["DB06838"],"chEBI":["49339"]},"childChemblIds":["CHEMBL1221959"],"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL539666","canonicalSmiles":"Clc1ccc2c(N3CCN(CCCN4CCN(c5ccnc6cc(Cl)ccc56)CC4)CC3)ccnc2c1.O=P(O)(O)O","inchiKey":"KATNPMSTHHZOTK-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PIPERAQUINE PHOSPHATE","maximumClinicalTrialPhase":2,"parentId":"CHEMBL303933","hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Piperaquine phosphate"],"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL549906","canonicalSmiles":"O=C(O)Cc1ccc(-c2c[nH]c3ncc(-c4ccc5ccccc5c4)cc23)cc1","inchiKey":"SWXKLXXVFMYMDP-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL549906","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB07837"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL550781","canonicalSmiles":"CCCCCN(CCCOC)C(=O)[C@@H](CCC(=O)O)NC(=O)c1ccc(Cl)c(Cl)c1","inchiKey":"QNQZBKQEIFTHFZ-GOSISDBHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"DEXLOXIGLUMIDE","maximumClinicalTrialPhase":3,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["CR-2017","Dexloxiglumide","Loxiglumide (r)-form","Loxiglumide, (r)-"],"crossReferences":{"Wikipedia":["Dexloxiglumide"],"drugbank":["DB04856"]},"linkedTargets":{"rows":["ENSG00000163394"],"count":1},"linkedDiseases":{"rows":["EFO_0000555","EFO_0008533"],"count":2},"description":"Small molecule drug with a maximum clinical trial phase of III (across all indications) and has 2 investigational indications."}
{"id":"CHEMBL55400","canonicalSmiles":"Nc1ccc2cc3ccc(N)cc3nc2c1","inchiKey":"WDVSHHCDHLJJJR-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PROFLAVINE","maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["Proflavine"],"crossReferences":{"PubChem":["29218003"],"Wikipedia":["Proflavine"],"drugbank":["DB01123"],"chEBI":["8452"]},"childChemblIds":["CHEMBL465704","CHEMBL1964546","CHEMBL606782","CHEMBL3186253","CHEMBL2105299"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) and has 6 investigational indications."}
{"id":"CHEMBL573677","canonicalSmiles":"C[C@H](CCOc1cccc(CC(=O)O)c1)N(Cc1cccc(C(F)(F)F)c1Cl)CC(c1ccccc1)c1ccccc1","inchiKey":"ZLJZDYOBXVOTSA-XMMPIXPASA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"RGX-104","maximumClinicalTrialPhase":1,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Abequolixron","RGX-104","Rgx-104","SB-742881"],"linkedTargets":{"rows":["ENSG00000131408","ENSG00000025434"],"count":2},"linkedDiseases":{"rows":["EFO_0000616"],"count":1},"description":"Small molecule drug with a maximum clinical trial phase of I and has 1 investigational indication."}
{"id":"CHEMBL58547","canonicalSmiles":"CC(C)(N)C(=O)N[C@@H](Cc1c[nH]cn1)C(=O)N[C@H](Cc1ccc2ccccc2c1)C(=O)N[C@H](Cc1ccccc1)C(=O)N[C@@H](CCCCN)C(N)=O","inchiKey":"NEHWBYHLYZGBNO-BVEPWEIPSA-N","drugType":"Protein","blackBoxWarning":false,"name":"IPAMORELIN","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["Aib-his-d-2-nal-d-phe-lys-nh2","Ipamorelin","NNC 26-0161","NNC-26-0161","NNC-260161"],"crossReferences":{"PubChem":["50112591"],"drugbank":["DB12370"]},"description":"Protein drug with a maximum clinical trial phase of II and has 1 investigational indication."}
{"id":"CHEMBL58752","canonicalSmiles":"O=[N+]([O-])c1nccn1CC(O)CN1CCCCC1","inchiKey":"WVWOOAYQYLJEFD-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"PIMONIDAZOLE","maximumClinicalTrialPhase":2,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["NSC-380540","PD 126675","PD-126675","Pimonidazole","RO 03-8799","RO-03-8799","RO-038799"],"crossReferences":{"PubChem":["470365"],"drugbank":["DB12485"]},"description":"Small molecule drug with a maximum clinical trial phase of II (across all indications) and has 4 investigational indications."}
{"id":"CHEMBL58832","canonicalSmiles":"NC(=O)C[C@H](N)C(=O)O","inchiKey":"DCXYFEDJOCDNAF-REOHCLBHSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ASPARAGINE","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["7ng0a2tuhq","Asparagine","Asparagine anhydrous","L-asparagine","L-asparagine anhydrous","NSC-82391"],"crossReferences":{"Wikipedia":["Asparagine"],"drugbank":["DB00174"],"chEBI":["17196"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL60851","canonicalSmiles":"O=C(O)CBr","inchiKey":"KDPAWGWELVVRCH-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"BROMOACETIC ACID","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":["2-Bromoacetic Acid","Bromo-Acetic Acid","Bromoacetic Acid"],"crossReferences":{"PubChem":["144207855","17389676"],"Wikipedia":["Bromoacetic_acid"],"drugbank":["DB02198"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL640","canonicalSmiles":"CCN(CC)CCNC(=O)c1ccc(N)cc1","inchiKey":"REQCZEXYDRLIBE-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"PROCAINAMIDE","yearOfFirstApproval":1950,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":[],"synonyms":["NSC-27461","Novocainamide","Procainamide","Procan","Procanbid","Procapan","Pronestyl","Pronestyl-SR","Sp 100 (pharmaceutical)"],"crossReferences":{"DailyMed":["procainamide%20hydrochloride"],"PubChem":["11111690","11111691","144203797","170464952","26751611","90340905"],"Wikipedia":["Procainamide"],"drugbank":["DB01035"],"chEBI":["8428"]},"childChemblIds":["CHEMBL605"],"linkedTargets":{"rows":["ENSG00000185313","ENSG00000196876","ENSG00000183873","ENSG00000136546","ENSG00000144285","ENSG00000169432","ENSG00000168356","ENSG00000007314","ENSG00000136531","ENSG00000153253"],"count":10},"linkedDiseases":{"rows":["EFO_0000275","EFO_0004269","EFO_0004287","EFO_0003144","EFO_0004278","HP_0004308","EFO_0000612"],"count":7},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1950 and is indicated for cardiac arrhythmia and ventricular arrhythmia and has 5 investigational indications. This drug has a black box warning from the FDA."}
{"id":"CHEMBL734","canonicalSmiles":"CC(=O)NO","inchiKey":"RRUDCFGSUDOHDG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"ACETOHYDROXAMIC ACID","yearOfFirstApproval":1983,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Lithostat"],"synonyms":["Acetohydroxamic acid","NSC-176136"],"crossReferences":{"DailyMed":["acetohydroxamic%20acid"],"PubChem":["144204853","170465439","26747835"],"Wikipedia":["Acetohydroxamic_acid"],"drugbank":["DB00551"],"chEBI":["27777"]},"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 1983 and is indicated for urinary tract infection and has 4 investigational indications."}
{"id":"CHEMBL91649","canonicalSmiles":"O=C(O)[C@H](Cc1c[nH]c2ccccc12)NS(=O)(=O)c1ccc(N2CCC(c3ccccc3)CC2)cc1","inchiKey":"ULOTXPTWJAUGGE-MHZLTWQESA-N","drugType":"Small molecule","blackBoxWarning":false,"name":"CHEMBL91649","maximumClinicalTrialPhase":0,"hasBeenWithdrawn":false,"isApproved":false,"tradeNames":[],"synonyms":[],"crossReferences":{"drugbank":["DB02449"]},"description":"Small molecule drug with a maximum clinical trial phase of I."}
{"id":"CHEMBL922","canonicalSmiles":"CC(C)(C)C(=O)OCOP(=O)(COCCn1cnc2c(N)ncnc21)OCOC(=O)C(C)(C)C","inchiKey":"WOZSCQDILHKSGG-UHFFFAOYSA-N","drugType":"Small molecule","blackBoxWarning":true,"name":"ADEFOVIR DIPIVOXIL","yearOfFirstApproval":2002,"maximumClinicalTrialPhase":4,"hasBeenWithdrawn":false,"isApproved":true,"tradeNames":["Adefovir dipivoxil","Hepsera"],"synonyms":["Adefovir di(pivaloyloxymethyl) ester","Adefovir dipivoxil","Adefovir pivoxil","GS-0840","Hepsera"],"crossReferences":{"DailyMed":["adefovir%20dipivoxil"],"PubChem":["144205796","170464742","174007317","26758046"],"drugbank":["DB00718"]},"childChemblIds":["CHEMBL537884"],"description":"Small molecule drug with a maximum clinical trial phase of IV (across all indications) that was first approved in 2002 and has 3 approved and 2 investigational indications. This drug has a black box warning from the FDA."}
